Molecule Details
InChIKeyIEEFWRMSEALUNN-UHFFFAOYSA-N
Compound Name4-[2-[(1E,3E,5E)-5-[3,3-dimethyl-1-[6-oxo-6-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]hexyl]-5-sulfoindol-2-ylidene]penta-1,3-dienyl]-3,3-dimethylindol-1-ium-1-yl]butane-1-sulfonate
Canonical SMILESCC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCN3CCN(CCCCC4CCN(CC(=O)N5c6ccccc6NC(=O)c6ccccc65)CC4)CC3)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Homologous
Avg pChEMBL7.81
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
P08172 CHRM2 Homo sapiens Human PF00001 8.7 Kd ChEMBL;BindingDB
P11229 CHRM1 Homo sapiens Human PF00001 8.4 Kd ChEMBL;BindingDB
P08173 CHRM4 Homo sapiens Human PF00001 8.0 IC50 ChEMBL;BindingDB
P20309 CHRM3 Homo sapiens Human PF00001 7.1 Ki ChEMBL;BindingDB
P08912 CHRM5 Homo sapiens Human PF00001 6.9 Ki ChEMBL;BindingDB